Gene · 3113
NIH grants1,839
NIH grants whose papers are about the gene, through NIH's grant-paper links.
421 to 440 of 1,839
Download this page as JSON| Grant | Title | HLA-DPA1 papers | Newest fiscal year |
|---|---|---|---|
| R01AG064877 | Genetic Architecture of Alzheimer’s disease Proteinopathies | 1 | 2024 |
| R01AG068110 | Tfh dysfunction in HIV and Aging | 1 | 2024 |
| R01AG069725 | Molecular, Epigenetic and Genomic Approaches to Understand Mechanisms of Aging in the Human Testis | 1 | 2024 |
| R01AI048638 | Metabolic imprinting of dendritic cell fate and function in tissues | 1 | 2024 |
| R01AI103867 | Structural correlates of T cell receptor signaling | 1 | 2024 |
| R01AI108906 | DNA Repair and Mitochondrial Dysfunction in T Cell Aging | 1 | 2024 |
| R01AI142841 | Maternal obesity and neonatal innate immunity | 1 | 2024 |
| R01AI145910 | Dysregulation of maternal immunity during pregnancy by pregravid obesity | 1 | 2024 |
| R01AI148161 | T cells in Lupus | 1 | 2024 |
| R01AI149672 | Defining Mechanisms of Viral Persistence in Situ at the Single-Cell Level | 1 | 2024 |
| R01CA168762 | Onset and biomarkers for progression of monoclonal gammopathies | 1 | 2024 |
| R01CA218094 | Deep learning based antibody design using high-throughput affinity testing of synthetic sequences | 1 | 2024 |
| R01CA242020 | Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia | 1 | 2024 |
| R01CA244359 | Targeting plasma membrane spatial dynamics to suppress aberrant Wnt signaling | 1 | 2024 |
| R01CA251245 | Targeting Prostate Cancer Lineage Plasticity with BET Bromodomain Inhibition | 1 | 2024 |
| R01CA262496 | Understanding Treatment Response Patterns And Therapy Resistance In IDH-Mutant AML | 1 | 2024 |
| R01DK121805 | MiR-150 regulated adiose tissue B cells in obesity | 1 | 2024 |
| R01EB015611 | Solar-Eclipse Computational Tools for Imaging Genetics | 1 | 2024 |
| R01GM083960 | IMP: Software for Hybrid Determination of Macromolecular Assembly Structures | 1 | 2024 |
| R01GM097171 | Evolutionary Genomics of Yeast | 1 | 2024 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3113/grants?page=22